the arrhythmia frequency established during the initial baseline has previously been reported to change during a second placebo monitoring period in patients with non-life-threatening ventricular arrhythmias , but the extent to which this applies to patients with nonsustained ventricular tachycardia has not been examined .
C0003811
arrhythmia
C0085612
ventricular